Eisai Regains Full Control Of ADC Program After Bristol R&D Reprioritization

 
• By Jessica Merrill
  
paper rip
Eisai and Bristol ended an ADC collaboration • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business